Addiction Treatment Under AHCA

Five hundred thousand Americans have died from opioid addiction in the last 15 years According the U.S. Centers for Disease Control and Prevention (CDC). The amount of deaths is four times that of the previous fifteen years. This an American crisis of addiction to opioids and the problem is only getting worse.  Because of this increase in use of opioids the issue has made it’s way into the forefront of American policy.

Financial Dilemma

Meanwhile, with the growing number of addicts, the availability of resources for recovery become less attainable and more costly. This creates a new financial dilemma that is hanging over the heads of the addicts in our communities and puts  pressure onto the policy makers in government.

Lack of Coverage

The severity of these issues then brings into question the Trump Era’s health care policies and his …

Continue Reading Addiction Treatment Under AHCA

Pros and Cons of Bunavail Approved by FDA

Pros

  •  Twice the bioavailability of Suboxone
  •  Promising alternative to methadone
  •  Treatment includes psychiatric therapy

Cons

  • Causes respiratory issues
  • Can cause death

Bio Delivery Sciences International’s new drug application has reached the final phase of approval by the FDA. Their supplemental application (sNDA) for Bunavail can step out of the management phase for opioid addiction patients and begin the use of the drug for treatment of opioid addiction.

Bunavail has twice the bioavailability of Suboxone film, which has increased it’s marketability ten fold and and therefore an attractive alternative for bottom line of the manufactures.

 

Bioavailability –  the proportion of a drug or other substance that enters the circulation when introduced into the body. When a drug is injected it has 100% bioavailability. Other means of administration have less than 100% bioavailability such as oral methods.

Bunavail will be administered …

Continue Reading Pros and Cons of Bunavail Approved by FDA